NEW YORK (dpa-AFX) – A sharp increase in inflation did not hurt the New York stock market on Wednesday. Consumer prices in the US rose by 7.0 percent compared to the same month last year. That’s the highest rate of inflation since 1982, but analysts were expecting it.
The leading index Dow Jones Industrial
The tech-heavy Nasdaq 100
Market observers now see interest rate hikes planned by the US Federal Reserve (Fed) as a reaction to high inflation and good economic development being incorporated into share prices. The Fed will probably tighten the monetary policy reins only gradually and at a pace that the financial markets can cope with, wrote strategist Marko Kolanovic of the investment bank JPMorgan. In addition, the tightening of monetary policy is likely to be flanked by a strong cyclical recovery in the economy, according to Kolanovic. He sees no real burden on stocks even in rising capital market yields and interest rate expectations. Rather, they speak for shifts from growth stocks to valuable paper.
The shares of Biogen were among the individual stocks in the middle of the week
In the Dow were the titles of the cloud computing specialist Salesforce
The Euro
On the bond market, the futures contract for ten-year Treasuries (T-Note Future) rose by 0.11 percent to 128.53 points. The yield on ten-year government bonds was 1.737 percent./ajx/he
— By Achim Jüngling, dpa-AFX —
ISIN US2605661048 US6311011026 US78378X1072
AXC0359 2022-01-12/22:36
Copyright dpa-AFX business news GmbH. All rights reserved. Redistribution, republication or permanent storage without the express prior consent of dpa-AFX is not permitted.
– .